HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Heeringa Selected Research

Messenger RNA (mRNA)

6/2012MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Heeringa Research Topics

Disease

8Glomerulonephritis
06/2012 - 03/2000
6Vasculitis (Vasculitides)
01/2021 - 08/2003
5Inflammation (Inflammations)
06/2012 - 02/2001
4Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
08/2010 - 11/2003
4Systemic Vasculitis
05/2009 - 11/2003
3Necrosis
08/2010 - 12/2003
3Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
05/2009 - 02/2001
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2017 - 05/2009
2Atherosclerosis
11/2008 - 12/2005
1Infections
01/2021
1Hemorrhagic Shock
06/2012
1Rheumatoid Arthritis
05/2009
1Atherosclerotic Plaque (Atheroma)
12/2005
1Pleurisy (Pleuritis)
07/2004
1Pneumonia (Pneumonitis)
07/2004
1Microscopic Polyangiitis
11/2003
1Churg-Strauss Syndrome (Allergic Angiitis)
11/2003
1Ulcerative Colitis
05/2002
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2002
1Nephritis
12/2001
1Vascular Diseases (Vascular Disease)
02/2001
1Thrombosis (Thrombus)
03/2000
1Proteinuria
03/2000

Drug/Important Bio-Agent (IBA)

10Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021 - 08/2003
4AutoantibodiesIBA
01/2017 - 05/2004
4Proteins (Proteins, Gene)FDA Link
06/2012 - 02/2001
4Peroxidase (Myeloperoxidase)IBA
10/2009 - 11/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2002 - 02/2001
2antiglomerular basement membrane antibodyIBA
06/2012 - 03/2000
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2010 - 02/2001
2Myeloblastin (Proteinase 3)IBA
05/2009 - 11/2003
2Immunoglobulin G (IgG)IBA
11/2008 - 04/2007
2CD40 Ligand (CD40L)IBA
11/2008 - 12/2005
2AntibodiesIBA
11/2008 - 08/2003
2Complement System Proteins (Complement)IBA
04/2007 - 01/2007
2Immunoglobulins (Immunoglobulin)IBA
01/2007 - 12/2003
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2002 - 02/2001
2Peroxynitrous Acid (Peroxynitrite)IBA
12/2001 - 02/2001
1Nuclear Proteins (Protein, Nuclear)IBA
01/2017
1HMGB1 Protein (HMG1)IBA
01/2017
1E-SelectinIBA
06/2012
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2012
1Messenger RNA (mRNA)IBA
06/2012
1LipopolysaccharidesIBA
08/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010
1ChemokinesIBA
10/2009
1Chemokine ReceptorsIBA
10/2009
1Peptide Hydrolases (Proteases)FDA Link
05/2009
1Immunoglobulin M (IgM)IBA
11/2008
1oxidized low density lipoproteinIBA
11/2008
1Apolipoproteins E (ApoE)IBA
11/2008
1Monoclonal AntibodiesIBA
04/2007
1Fas Ligand Protein (Fas Ligand)IBA
07/2004
1Antigen-Antibody Complex (Immune Complex)IBA
12/2003
1HLA-DR Antigens (HLA-DR)IBA
05/2002
1Fibrinogen (Factor I)FDA Link
12/2001
1anti-Thy antibodyIBA
12/2001
1Superoxides (Superoxide)IBA
12/2001
1Nitric Oxide Synthase (NO Synthase)IBA
02/2001
1NitrogenIBA
03/2000
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
03/2000
1Urea (Carbamide)FDA LinkGeneric
03/2000

Therapy/Procedure

1Intravenous Injections
07/2004